SCHEMBL687550

SCHEMBL687550

N#CCc1nc2ccccc2o1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
NPC1 O15118 4/20 0.63
RAB9A P51151 4/20 0.63
TP53 P04637 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
LMNA P02545 1/20 0.58
LOXL2 Q9Y4K0 1/20 0.56
PSMB8 P28062 1/20 0.55
HTT P42858 1/20 0.49
GFER P55789 1/20 0.49
HBB P68871 1/20 0.47
EGFR P00533 1/20 0.46
USP2 O75604 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
DDAH1 O94760 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7033308 0.81 MAPT (0.63) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7660532 0.81 MAPT (0.63) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL11333912 0.79 GAA (0.59) MAPTNPC1RAB9ASMN1; SMN2HBB
SCHEMBL13053146 0.79 MAPT (0.59) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL30010034 0.79 MAPT (0.43) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL155002 0.78 MAPT (1.00) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL1420033 0.78 TP53 (0.81) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL11331561 0.77 KDM4E (0.51) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL9272963 0.77 RAB9A (0.58) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL16515861 0.76 CETP (0.42) PSMB8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12180201-B1 2-(benzo[d]oxazol-2-yl)-N′-(isonicotinoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-12-31 US claimed
US-12122770-B1 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-10-22 US claimed
US-12060335-B1 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-08-13 US claimed
US-11905280-B1 2-(benzo[d]oxazol-2-yl)-N'-(picolinoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-02-20 US claimed
CN-117580614-A Compositions and methods for increasing sensitivity of cancer cells to alternating electric fields 诺沃库勒有限责任公司 2024-02-20 CN claimed
US-11905259-B1 2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-02-20 US claimed
CN-117402464-A Blue light-proof composite master batch 上海沪正实业有限公司 2024-01-16 CN claimed
CN-114656493-A Dye pyrrolopyrrole cyanine compound with aggregation-induced emission and near-infrared emission and preparation method thereof 华南理工大学 2022-06-24 CN claimed
EP-2450348-B1 NOVEL DIARYLAMINE COMPOUND, AND ANTI-AGING AGENT, POLYMER COMPOSITION, CROSSLINKED RUBBER PRODUCT AND MOLDED ARTICLE THEREOF, AND METHOD FOR PRODUCING DIARYLAMINE COMPOUND ZEON CORP (JP) 2016-12-14 EP claimed
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 US claimed
US-20070185104-A1 Benzoxazole acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-08-09 US claimed
JP-2007505085-A 2007-03-08 JP claimed
EP-1667995-A1 BENZIMIDAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 EP claimed
EP-1668004-A1 BENZOXAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 EP claimed
WO-2005026155-A1 BENZIMIDAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO claimed
WO-2005026159-A1 BENZOXAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO claimed
EP-0453395-B1 Pressure sensitive recording material CIBA GEIGY AG (CH) 1995-11-02 EP claimed
US-5254522-A Pressure-sensitive or heat-sensitive recording material CIBA-GEIGY CORPORATION (US) 1993-10-19 US claimed
EP-0453395-A1 Pressure sensitive recording material CIBA-GEIGY AG (CH) 1991-10-23 EP claimed
JP-11292875-A None JP disclosed
US-12180201-B1 2-(benzo[d]oxazol-2-yl)-N′-(isonicotinoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-12-31 US disclosed
US-12122770-B1 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-10-22 US disclosed
CN-118652242-B Aggregation-induced emission type photosensitizer with I-type active oxygen generation capacity and preparation method and application thereof 内蒙古大学 2024-10-18 CN disclosed
CN-118652242-A Aggregation-induced emission type photosensitizer with I-type active oxygen generation capacity and preparation method and application thereof 内蒙古大学 2024-09-17 CN disclosed
US-12060335-B1 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-08-13 US disclosed
US-11970468-B1 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-04-30 US disclosed
CN-117580614-A Compositions and methods for increasing sensitivity of cancer cells to alternating electric fields 诺沃库勒有限责任公司 2024-02-20 CN disclosed
US-11905280-B1 2-(benzo[d]oxazol-2-yl)-N'-(picolinoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-02-20 US disclosed
US-11905259-B1 2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound King Faisal University (SA) 2024-02-20 US disclosed
CN-117402464-A Blue light-proof composite master batch 上海沪正实业有限公司 2024-01-16 CN disclosed
CN-114656493-B Fluorescent dye pyrrolopyrrole cyanine compound with aggregation-induced emission and near infrared emission and preparation method thereof 华南理工大学 2023-11-28 CN disclosed
CN-114656493-B Fluorescent dye pyrrolopyrrole cyanine compound with aggregation-induced emission and near infrared emission and preparation method thereof 华南理工大学 2023-11-28 CN disclosed
US-20230002769-A1 APTAMER NUCLEIC ACID MOLECULE, AND COMPLEX AND APPLICATION THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-01-05 US disclosed
US-20220214351-A1 FLUORESCENT DYE, PREPARATION METHOD AND USES THEREOF FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD. (CN) 2022-07-07 US disclosed
CN-114656493-A Dye pyrrolopyrrole cyanine compound with aggregation-induced emission and near-infrared emission and preparation method thereof 华南理工大学 2022-06-24 CN disclosed
CN-114656493-A Dye pyrrolopyrrole cyanine compound with aggregation-induced emission and near-infrared emission and preparation method thereof 华南理工大学 2022-06-24 CN disclosed
US-11365203-B2 Fluorescent dye and preparation method and use thereof FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD. (CN) 2022-06-21 US disclosed
US-11365203-B2 Fluorescent dye and preparation method and use thereof FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD. (CN) 2022-06-21 US disclosed
US-11209437-B2 Fluorescent probe and preparation method and use thereof FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) 2021-12-28 US disclosed
WO-2021057816-A1 NUCLEIC ACID APTAMER MOLECULE 华东理工大学 2021-04-01 WO disclosed
US-20200248069-A1 FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-08-06 US disclosed
CN-107663384-B Fluorescent dye and preparation method and application thereof 上海高驰资产管理有限公司 2020-05-12 CN disclosed
US-10392389-B2 Heterocyclic compounds for the inhibition of PASK BIOENERGENIX LLC (US) 2019-08-27 US disclosed
US-10392389-B2 Heterocyclic compounds for the inhibition of PASK BIOENERGENIX LLC (US) 2019-08-27 US disclosed
US-20190241584-A1 FLUORESCENT DYE AND PREPARATION METHOD AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-08-08 US disclosed
US-20190241584-A1 FLUORESCENT DYE AND PREPARATION METHOD AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-08-08 US disclosed
WO-2019152731-A1 ANDROGEN RECEPTOR ANTAGONISTS ALPINE ANDROSCIENCES, INC. (US) 2019-08-08 WO disclosed
US-20190196073-A1 COMPOSITION, FILM, NEAR INFRARED CUT FILTER, PATTERN FORMING METHOD, LAMINATE, SOLID IMAGE PICKUP ELEMENT, IMAGE DISPLAY DEVICE, CAMERA MODULE, AND INFRARED SENSOR FUJIFILM CORPORATION (JP) 2019-06-27 US disclosed
US-20190187144-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-06-20 US disclosed
EP-3489323-A1 FLUORESCENT DYE AND PREPARATION METHOD AND USE THEREOF East China University of Science and Technology (CN) 2019-05-29 EP disclosed
EP-3489324-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF East China University of Science and Technology (CN) 2019-05-29 EP disclosed
US-20170351014-A1 NEAR-INFRARED ABSORPTION COMPOSITION, CURED FILM, NEAR-INFRARED ABSORPTION FILTER, SOLID-STATE IMAGING DEVICE, AND INFRARED SENSOR FUJIFILM CORPORATION (JP) 2017-12-07 US disclosed
US-20170351014-A1 NEAR-INFRARED ABSORPTION COMPOSITION, CURED FILM, NEAR-INFRARED ABSORPTION FILTER, SOLID-STATE IMAGING DEVICE, AND INFRARED SENSOR FUJIFILM CORPORATION (JP) 2017-12-07 US disclosed
US-9677115-B2 Enzyme substrates for visualizing acidic organelles MARKER GENE TECHNOLOGIES, INC. (US) 2017-06-13 US disclosed
US-9434720-B2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents DIRMIRA (CANADA), INC. (US) 2016-09-06 US disclosed
US-20150284395-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX LLC 2015-10-08 US disclosed
US-20150284395-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX LLC 2015-10-08 US disclosed
US-20140350009-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS DERMIRA (CANADA), INC. (US) 2014-11-27 US disclosed
US-8754233-B2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents DERMIRA (CANADA), INC. (US) 2014-06-17 US disclosed
WO-2014066795-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2014-05-01 WO disclosed
WO-2014066795-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2014-05-01 WO disclosed
US-20130252268-A1 Enzyme substrates for visualizing acidic organelles MARKER GENE TECHNOLOGIES, INC. (US) 2013-09-26 US disclosed
US-20130237572-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS DERMIRA (CANADA), INC. (US) 2013-09-12 US disclosed
US-8410272-B2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents DERMIRA (CANADA), INC. (US) 2013-04-02 US disclosed
US-20130072473-A1 COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS PROTEOSTASIS THERAPEUTICS, INC. 2013-03-21 US disclosed
US-20130072473-A1 COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS PROTEOSTASIS THERAPEUTICS, INC. 2013-03-21 US disclosed
US-20130072473-A1 COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS PROTEOSTASIS THERAPEUTICS, INC. 2013-03-21 US disclosed
CN-102875541-A Preparation method of 3-(2-benzoxazolyl)-7-hydroxy coumarin TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY CO LTD 2013-01-16 CN disclosed
CN-102875486-A Preparation method of 2-benzoxazole acetonitrile TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY CO LTD 2013-01-16 CN disclosed
CN-102875541-A Preparation method of 3-(2-benzoxazolyl)-7-hydroxy coumarin TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY CO LTD 2013-01-16 CN disclosed
CN-102875486-A Preparation method of 2-benzoxazole acetonitrile TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY CO LTD 2013-01-16 CN disclosed
CN-102875486-A Preparation method of 2-benzoxazole acetonitrile TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY CO LTD 2013-01-16 CN disclosed
WO-2012154888-A1 COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS PROTEOSTASIS THERAPEUTICS, INC. (US) 2012-11-15 WO disclosed
WO-2012154888-A1 COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS PROTEOSTASIS THERAPEUTICS, INC. (US) 2012-11-15 WO disclosed
EP-1542997-B1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS DERMIRA CANADA INC (CA) 2012-02-29 EP disclosed
US-20110178126-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Valocor Therapeutics, Inc. (CA) 2011-07-21 US disclosed
US-7847101-B2 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors Valocor Therapeutics, Inc. (CA) 2010-12-07 US disclosed
EP-1258481-B1 Enaminotriazines as UV filters BASF SE (DE) 2008-06-18 EP disclosed
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 US disclosed
US-20070185104-A1 Benzoxazole acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-08-09 US disclosed
US-20070185104-A1 Benzoxazole acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-08-09 US disclosed
US-20070185104-A1 Benzoxazole acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-08-09 US disclosed
US-20070185104-A1 Benzoxazole acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-08-09 US disclosed
US-20070185104-A1 Benzoxazole acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-08-09 US disclosed
US-7217820-B2 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines BASF AKTIENGESELLSCHAFT (DE) 2007-05-15 US disclosed
US-20060247210-A1 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors QLT INC. (CA) 2006-11-02 US disclosed
EP-1667995-A1 BENZIMIDAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 EP disclosed
EP-1668004-A1 BENZOXAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 EP disclosed
EP-1668004-A1 BENZOXAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 EP disclosed
EP-1542997-A2 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS QLT, Inc. (CA) 2005-06-22 EP disclosed
US-6887460-B2 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines BASF AKTIENGESELLSCHAFT (DE) 2005-05-03 US disclosed
US-20050089487-A1 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines HEIDENFELDER THOMAS (DE) 2005-04-28 US disclosed
WO-2005026159-A1 BENZOXAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed
WO-2005026159-A1 BENZOXAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed
WO-2005026155-A1 BENZIMIDAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed
US-6835845-B2 For use as a dye for a filter, a color conversion filter, a dye for a photographic material, a sensitizing dye, a dye for pulp dyeing, a laser dye, a fluorescent medicine for a medical diagnosis FUJI PHOTO FILM CO., LTD. (JP) 2004-12-28 US disclosed
US-6835474-B2 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers FUJI PHOTO FILM CO., LTD. (JP) 2004-12-28 US disclosed
WO-2004108722-A1 ORTHOCONDENSED POLYCYCLIC AMINOPYRROLE DERIVATIVES COMPRISING AN ELECTRO-ATTRACTIVE SUBSTITUENT, COMBINATION PRODUCTS OF SAID DERIVATIVES, AND METHOD FOR THE PRODUCTION THEREOF PIERRE FABRE UROLOGIE (FR) 2004-12-16 WO disclosed
EP-1016653-B1 Preparation of high-dye yield couplers and intermediates useful therein EASTMAN KODAK CO (US) 2004-02-25 EP disclosed
WO-2004011460-A2 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS QLT, INC. (CA) 2004-02-05 WO disclosed
EP-1189889-B1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH ELAN PHARMA INT LTD (IE) 2003-12-17 EP disclosed
US-6638701-B1 Element containing pyrazolotriazole coupler having certain carbonamido containing substituent that provides red dye having improved light stability EASTMAN KODAK COMPANY 2003-10-28 US disclosed
EP-1353222-A1 Photographic element containing azole couplers EASTMAN KODAK COMPANY (US) 2003-10-15 EP disclosed
US-20030134148-A1 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same FUJI PHOTO FILM CO., LTD. 2003-07-17 US disclosed
US-20030080323-A1 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same FUJI PHOTO FILM CO., LTD. 2003-05-01 US disclosed
US-6541486-B1 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. ELAN PHARMA INTERNATIONAL LTD. (IE) 2003-04-01 US disclosed
US-20030044363-A1 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines BASF AKTIENGESELLSCHAFT (DE) 2003-03-06 US disclosed
US-6521397-B1 Support bearing light sensitive silver halide emulsion layer having associated such as 2-benzoazoacetoitrile derivative dye forming coupler; improved absorption maximum and color gamut EASTMAN KODAK COMPANY 2003-02-18 US disclosed
US-6506507-B1 Novel compound suitable for use as a dye for a filter, a color conversion filter, a dye for a photographic material, a sensitizing dye, a dye for pulp dyeing, a laser dye, a fluorescent medicine FUJI PHOTO FILM CO., LTD. (JP) 2003-01-14 US disclosed
EP-1258481-A1 Enaminotriazines as UV filters BASF AKTIENGESELLSCHAFT (DE) 2002-11-20 EP disclosed
US-6458474-B1 PYRAZOLIDINE-3,5-DIONE DERIVATIVES; RED FLUORESCENT METHINE DYES; COLOR PURITY FUJI PHOTO FILM CO., LTD. (JP) 2002-10-01 US disclosed
EP-1189889-A1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH Elan Pharma International Limited (IE) 2002-03-27 EP disclosed
US-6172260-B1 Preparation of high dye-yield couplers and intermediates useful therein EASTMAN KODAK COMPANY 2001-01-09 US disclosed
WO-2000075117-A1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH ELAN PHARMA INTERNATIONAL LTD. (IE) 2000-12-14 WO disclosed
EP-1052261-A1 PYRAN DERIVATIVES AND USE THEREOF Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2000-11-15 EP disclosed
US-6132944-A A FORMED CARBAMYLOXY GROUP OR A SULFONYLISOCYANATO GROUP LINKED A COUPLER AND A DYE; EXHIBIT A HIGHER REACTIVITY WITH OXIDIZED DEVELOPER EASTMAN KODAK COMPANY (US) 2000-10-17 US disclosed
EP-1016916-A1 Photographic element containing high dye-yield couplers EASTMAN KODAK COMPANY (US) 2000-07-05 EP disclosed
EP-1016653-A1 Preparation of high-dye yield couplers and intermediates useful therein EASTMAN KODAK COMPANY (US) 2000-07-05 EP disclosed
JP-H11292875-A NEW METHINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME FUJI PHOTO FILM CO LTD 1999-10-26 JP disclosed
EP-0453395-B1 Pressure sensitive recording material CIBA GEIGY AG (CH) 1995-11-02 EP disclosed
US-5254522-A Pressure-sensitive or heat-sensitive recording material CIBA-GEIGY CORPORATION (US) 1993-10-19 US disclosed
US-4579939-A YELLOW DYES FOR DYEING POLYESTER FIBERS EASTMAN KODAK COMPANY (US) 1986-04-01 US disclosed
EP-0047881-B1 DIMETHINE COMPOUNDS OF THE COUMARINE SERIES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS LUMINESCENT DYESTUFFS BAYER AG (DE) 1984-03-14 EP disclosed
US-4384973-A RED/ORANGE POLYESTER FLUORESCENT DYE BAYER AKTIENGESELLSCHAFT (DE) 1983-05-24 US disclosed
EP-0012300-B1 COLOURED POLYMERIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION TO THE DYEING OF PAPER BASF Aktiengesellschaft (DE) 1982-12-01 EP disclosed
EP-0047881-A2 Dimethine compounds of the coumarine series, process for their preparation and their use as luminescent dyestuffs BAYER AG (DE) 1982-03-24 EP disclosed
US-4268668-A FOR WOOL AND POLYAMIDES BAYER AKTIENGESELLSCHAFT (DE) 1981-05-19 US disclosed
US-4267319-A CATIONIC DYES AND N-HETEROCYCLIC CATIONIC POLYMERS; PRINTING PAPER; ORANGE OR RED BASF AKTIENGESELLSCHAFT (DE) 1981-05-12 US disclosed
US-4237293-A COLORFAST SHADES OF YELLOW TO RED FOR PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4237286-A COLORING PLASTICS AND LACQUERS IN YELLOW TO RED SHADES CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4237292-A SHADES OF YELLOW TO RED FOR PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
EP-0012300-A2 Coloured polymeric compounds, process for their preparation and their application to the dyeing of paper BASF Aktiengesellschaft (DE) 1980-06-25 EP disclosed
US-4146712-A PROCESS FOR THE MANUFACTURE OF COUMARIN DYES CIBA-GEIGY CORPORATION (US) 1979-03-27 US disclosed
US-4132708-A Metal complexes of azomethines and process for their manufacture CIBA-GEIGY CORPORATION (US) 1979-01-02 US disclosed
US-4113718-A Basic azo dyes CIBA-GEIGY CORPORATION (US) 1978-09-12 US disclosed
US-4111947-A DYES, PLASTICS, LACQUERS CIBA-GEIGY CORPORATION (US) 1978-09-05 US disclosed
US-4097484-A ORGANIC PIGMENTS, PLASTICS CIBA-GEIGY CORPORATION (US) 1978-06-27 US disclosed
US-4064136-A FROM A NITRILE, AN ALCOHOL AND ORTHO-SUBSTITUTED AROMATIC AMINE CIBA-GEIGY AG (CH) 1977-12-20 US disclosed
US-4051099-A ISOINDOLES CIBA-GEIGY CORPORATION (US) 1977-09-27 US disclosed
US-4022770-A COLORING CIBA-GEIGY CORPORATION (US) 1977-05-10 US disclosed
US-4002635-A FOR COLORING PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1977-01-11 US disclosed
US-4002635-A FOR COLORING PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1977-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (24 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12122770-B1 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound NIT2, B3GNT2, NAAA MAPT 3029/4885NPC1 1314/4885RAB9A 3753/4885
US-11970468-B1 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound AADAC, ACMSD, NAALAD2 MAPT 4123/4885NPC1 2581/4885RAB9A 3456/4885
US-20060247210-A1 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors TST, PTK2, PTK2B MAPT 4331/4885NPC1 4326/4885RAB9A 4041/4885
US-20130072473-A1 COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS HSPA5, PSMG3, VCP MAPT 221/4885NPC1 809/4885RAB9A 858/4885
US-12180201-B1 2-(benzo[d]oxazol-2-yl)-N′-(isonicotinoyloxy)acetimidamide as an antimicrobial compound AADAC, B3GNT2, OXA1L MAPT 2366/4885NPC1 1591/4885RAB9A 3709/4885
US-20070203134-A1 Benzimidazole Acetonitriles PKD1, GPR119, CCNI MAPT 4873/4885NPC1 984/4885RAB9A 4340/4885
US-20190187144-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF HNRNPF, HNRNPUL2, RAB5IF MAPT 2624/4885NPC1 1998/4885RAB9A 1864/4885
US-10392389-B2 Heterocyclic compounds for the inhibition of PASK PASK, PDXK, PANK2 MAPT 3629/4885NPC1 3570/4885RAB9A 983/4885
US-11905280-B1 2-(benzo[d]oxazol-2-yl)-N'-(picolinoyloxy)acetimidamide as an antimicrobial compound AADAC, NAALAD2, OXA1L MAPT 2915/4885NPC1 1593/4885RAB9A 3811/4885
US-20230002769-A1 APTAMER NUCLEIC ACID MOLECULE, AND COMPLEX AND APPLICATION THEREOF DNTT, TIA1, TIAL1 MAPT 2343/4885NPC1 3833/4885RAB9A 4041/4885
US-20200248069-A1 FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF WASF2, FAM162A, HASPIN MAPT 3407/4885NPC1 1881/4885RAB9A 3069/4885
US-20110178126-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS REN, PGF, PKD1 MAPT 4282/4885NPC1 3923/4885RAB9A 2638/4885
US-20030044363-A1 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines ARSA, AASDHPPT, HRH1 MAPT 4429/4885NPC1 4290/4885RAB9A 4145/4885
US-12060335-B1 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound AADAC, ACMSD, NAALAD2 MAPT 4123/4885NPC1 2581/4885RAB9A 3456/4885
US-20050089487-A1 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines ARSA, AASDHPPT, TYR MAPT 4363/4885NPC1 4416/4885RAB9A 4232/4885
US-20130237572-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS COXFA4L2, TYR, XDH MAPT 865/4885NPC1 404/4885RAB9A 3096/4885
US-20190241584-A1 FLUORESCENT DYE AND PREPARATION METHOD AND USE THEREOF DNASE1, POLRMT, DCLRE1B MAPT 2048/4885NPC1 3090/4885RAB9A 2044/4885
US-20140350009-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS COXFA4L2, TYR, XDH MAPT 865/4885NPC1 404/4885RAB9A 3096/4885
US-20030080323-A1 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same METTL3, LUC7L2, EMG1 MAPT 3989/4885NPC1 3313/4885RAB9A 2751/4885
US-11209437-B2 Fluorescent probe and preparation method and use thereof HNRNPF, HNRNPUL2, RAB5IF MAPT 2624/4885NPC1 1998/4885RAB9A 1864/4885
US-11905259-B1 2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound AADAC, ACMSD, NAAA MAPT 3751/4885NPC1 2197/4885RAB9A 3756/4885
US-20070185104-A1 Benzoxazole acetonitriles PKD1, PC, GPR119 MAPT 4882/4885NPC1 1847/4885RAB9A 4160/4885
US-20150284395-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK PASK, PDXK, PANK2 MAPT 3629/4885NPC1 3570/4885RAB9A 983/4885
US-11365203-B2 Fluorescent dye and preparation method and use thereof DNASE1, POLRMT, DCLRE1B MAPT 2048/4885NPC1 3090/4885RAB9A 2044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.